본문 바로가기

ICH

ICH Q10 Annex 1

Annex 1

조항 원문

Potential Opportunities to Enhance Science and Risk Based Regulatory Approaches * *Note: This annex reflects potential opportunities to enhance regulatory approaches.

The actual regulatory process will be determined by region.

Scenario Potential Opportunity

1. Comply with GMPs Compliance – status quo

2. Demonstrate effective Opportunity to: pharmaceutical quality system, • increase use of risk based including effective use of quality approaches for regulatory risk management principles (e.g., inspections. ICH Q9 and ICH Q10).

3. Demonstrate product and process Opportunity to: understanding, including effective • facilitate science based use of quality risk management pharmaceutical quality principles (e.g., ICH Q8 and ICH assessment; Q9). • enable innovative approaches to process validation;

• establish real-time release mechanisms.

4. Demonstrate effective Opportunity to: pharmaceutical quality system • increase use of risk based and product and process approaches for regulatory understanding, including the use inspections; of quality risk management • facilitate science based principles (e.g., ICH Q8, ICH Q9 pharmaceutical quality and ICH Q10). assessment;

• optimise science and risk based post-approval change processes to maximise benefits from innovation and continual improvement;

• enable innovative approaches to process validation;

• establish real-time release mechanisms.

본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.

출처: International Council for Harmonisation (ICH) · © ICH. Per the legal notice in each guideline, the document may be used, reproduced and distributed provided ICH's copyright is acknowledged; any adaptation or translation must be labelled as such and must not imply ICH endorsement. · 수집일 2026-11-15

Weekly Newsletter

이런 지적, 매주 월요일 한국어로 받아보세요

FDA·EMA·식약처의 새 지적과 조치를 공식 원문 링크와 함께 보내드립니다. 사이트에 새로운 기능이 생기면 함께 안내드립니다. 구독은 언제든 한 번의 클릭으로 해지할 수 있습니다.

이번 주 소식 먼저 보기

매주 월요일 발송 · 구독 신청 시 확인 메일이 발송됩니다 · 수신거부는 모든 메일 하단에서 가능합니다.